Antibody-guided drug works against acute lymphoblastic leukemia
Monday, May 23, 2011 - 16:30
in Health & Medicine
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study.